Aurobindo Irbesartan Class Action Settlement — $2 Million for Contaminated Blood Pressure Drug, Claim by June 2, 2026

BySteve LevinePublished: April 6, 2026TweetShareStatusClaims Openfinal approval hearing scheduled June 30, 2026Claim DeadlineJune 2, 2026Settlement Fund$2,000,000economic loss only · pro rata refund · class period Jan 1, 2016 – presentProof RequiredNodocumentation encouraged but not strictly required · Aurobindo IC ROS irbesartanWhat Is This Settlement About?Aurobindo Pharma Ltd., Aurobindo Pharma USA Inc., and Aurolife Pharma LLC have agreed to a $2,000,000 class action settlement to resolve ec